MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature

Women living with androgenic PCOS (WLWP) experience unpredictable oligomenorrhea(1) and are at increased risk for endometrial cancer(2). Oral micronized progesterone (OMP) given cyclically (14 days/cycle or 4 weeks, Cyclic OMP), in luteal phase doses(3) (300 mg at bedtime) as a “luteal phase replace...

詳細記述

保存先:
書誌詳細
出版年:J Endocr Soc
主要な著者: Shirin, Sonia, Goshtasebi, Azita, Kalidasan, Dharani, Prior, Jerilynn C
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Reproductive Endocrinology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209032/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2339
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料